Press Releases

Press Releases

Search by keywords:

184 Press Releases found

Rare Medical Phenomenon Of Systemic Tumor Disappearance Following Local Radiation Treatment Reported In A Patient With Metastatic Melanoma

A rarely seen phenomenon in cancer patients — in which focused radiation to the site of one tumor is associated with the disappearance of metastatic tumors all over the body — has been reported in a patient with melanoma treated with the immunotherapeutic agent ipilimumab (Yervoy™).

  • Thursday, March 8, 2012

Colonoscopy Prevents Deaths From Colon Cancer

For the first time, a new study has shown that removing polyps by colonoscopy not only prevents colorectal cancer from developing, but also prevents deaths from the disease. Patients in the study were evaluated for up to 23 years after having the procedure, providing the longest follow-up results to date.

  • Wednesday, February 22, 2012

Cycle for Survival Event Advances Research and Treatments for Rare Cancers

More than 10,000 people nationwide will participate in Memorial Sloan Kettering Cancer Center’s sixth annual Cycle for Survival event taking place this February at Equinox clubs in New York City, Long Island, Washington D.C., Chicago, San Francisco, and Los Angeles.

  • Wednesday, February 1, 2012

Targeted Therapy Improves Overall Survival in Men with Late-Stage Prostate Cancer

The investigational oral drug MDV3100 significantly improved overall survival in patients with advanced prostate cancer, results of a large, phase III study show.

  • Tuesday, January 31, 2012

Memorial Sloan Kettering Receives $50 Million in Honor of Josie Robertson

As a tribute to Memorial Sloan Kettering Board member Josephine “Josie” Robertson, Memorial Sloan Kettering has joined with The Robertson Foundation to undertake two high-profile initiatives — the Josie Robertson Surgery Center and the Josie Robertson Investigators Program — made possible by a $50 million commitment from The Robertson Foundation.

  • Wednesday, December 21, 2011

Experimental Treatment Could Improve Stem Cell Transplants

A Memorial Sloan Kettering Cancer Center study suggests that a new, experimental treatment could make bone marrow and stem cell transplantation more effective and safe.

  • Saturday, December 10, 2011

Researchers Discover Why New Melanoma Drug Stops Working

Research led by investigators at Memorial Sloan Kettering has identified a previously unknown mechanism of resistance to the newly approved melanoma drug, vemurafenib.

  • Wednesday, November 23, 2011

City of Hope and Memorial Sloan Kettering Receive NCI Grant to Train Nurses Caring for Cancer Survivors

A five-year grant of more than $1.4 million will fund a program to train nurses in helping survivors achieve the best possible quality of life after cancer.

  • Monday, October 17, 2011

Three Young Investigators Named Winners of Paul Marks Prize for Cancer Research

Memorial Sloan Kettering Cancer Center will recognize three young investigators for their exceptional bodies of innovative work that has helped to advance the field of cancer research. The researchers will receive the Paul Marks Prize for Cancer Research, an award presented biennially by Memorial Sloan Kettering to honor promising scientists under the age of 46.

  • Tuesday, September 20, 2011

Gene Mutation Contributes To Leukemia By Enhancing Function Of Blood Stem Cells

Memorial Sloan Kettering researchers helped to identify a key insight into what first goes wrong in the development of many leukemias.

  • Thursday, June 30, 2011